From a mechanistic perspective, SCCOHT is the most well-characterized of BRG1-null cancers, although SMARCA4 mutations also occur in up to 10% of non-small cell lung cancers sequenced [51]. Here, SMARCA4 is linked to non-small cell lung carcinoma.